Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiqing Du

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Pharmacological Research|December 11, 2024
Efficacy and safety of selective pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors in FGFR-altered urothelial carcinomaYuxuan Song, Yiqing Du, Shan Jiang, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 21, 2021
Predicting ureteral status below the ureteral calculi in patients undergoing ureteroscopic lithotomyCaipeng Qin, Huaqi Yin, Yiqing Du, et al.
World Neurosurgery|November 29, 2011
Relationship between learning and memory deficits and Arp2 expression in the hippocampus in rats with traumatic brain injuryXuewei Xia, Yuwei Dong, Yiqing Du, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 15, 2019
Clear cell renal cell carcinoma bone metastasis: What should be considered in prognostic evaluationZixiong Huang, Yiqing Du, Xiaopeng Zhang, et al.
Fitoterapia|May 13, 2024
New flavonoid and their anti-A549 cell activity from the bi-directional solid fermentation products of Astragalus membranaceus and Cordyceps kyushuensisHuixin Cheng, Yiqing Du, Jiajia Hu, et al.
Pharmacological Research|May 24, 2024
Effect of FGFR alteration on prognosis in 1963 urothelial carcinoma patients with immune checkpoint inhibitors: Implying combination of FGFR inhibitor and immunotherapy for FGFR-altered urothelial carcinomaYuxuan Song, Shan Jiang, Yun Peng, et al.
Bladder (San Francisco, Calif.)|December 1, 2025
Clinical significance of tumor location in non-muscle-invasive bladder cancer: A single-center longitudinal cohort analysisCaipeng Qin, Yun Peng, Fei Wang, et al.
Annals of Medicine|November 14, 2023
Three versus four cycles of neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysisYulong Wang, Yuxuan Song, Caipeng Qin, et al.
Urologic Oncology|May 10, 2024
Effects of androgen suppression therapy on the incidence and prognosis of bladder cancer: An updated systematic review and meta-analysisYulong Wang, Yuxuan Song, Yun Peng, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2023
GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and femalesYuxuan Song, Caipeng Qin, Chunlong Zhang, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Pharmacological Research|December 11, 2024
Efficacy and safety of selective pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors in FGFR-altered urothelial carcinomaYuxuan Song, Yiqing Du, Shan Jiang, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|January 21, 2021
Predicting ureteral status below the ureteral calculi in patients undergoing ureteroscopic lithotomyCaipeng Qin, Huaqi Yin, Yiqing Du, et al.
World Neurosurgery|November 29, 2011
Relationship between learning and memory deficits and Arp2 expression in the hippocampus in rats with traumatic brain injuryXuewei Xia, Yuwei Dong, Yiqing Du, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 15, 2019
Clear cell renal cell carcinoma bone metastasis: What should be considered in prognostic evaluationZixiong Huang, Yiqing Du, Xiaopeng Zhang, et al.
Fitoterapia|May 13, 2024
New flavonoid and their anti-A549 cell activity from the bi-directional solid fermentation products of Astragalus membranaceus and Cordyceps kyushuensisHuixin Cheng, Yiqing Du, Jiajia Hu, et al.
Pharmacological Research|May 24, 2024
Effect of FGFR alteration on prognosis in 1963 urothelial carcinoma patients with immune checkpoint inhibitors: Implying combination of FGFR inhibitor and immunotherapy for FGFR-altered urothelial carcinomaYuxuan Song, Shan Jiang, Yun Peng, et al.
Bladder (San Francisco, Calif.)|December 1, 2025
Clinical significance of tumor location in non-muscle-invasive bladder cancer: A single-center longitudinal cohort analysisCaipeng Qin, Yun Peng, Fei Wang, et al.
Annals of Medicine|November 14, 2023
Three versus four cycles of neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and meta-analysisYulong Wang, Yuxuan Song, Caipeng Qin, et al.
Urologic Oncology|May 10, 2024
Effects of androgen suppression therapy on the incidence and prognosis of bladder cancer: An updated systematic review and meta-analysisYulong Wang, Yuxuan Song, Yun Peng, et al.
Journal of Cancer Research and Clinical Oncology|February 22, 2023
GNRH family genes contributed to gender-specific disparity of bladder cancer prognosis through exerting opposite regulatory roles between males and femalesYuxuan Song, Caipeng Qin, Chunlong Zhang, et al.
Pageof 7